Related Experiment Video
Updated: Nov 10, 2025

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
SRSF9 Regulates Cassette Exon Splicing of Caspase-2 by Interacting with Its Downstream Exon
Jiyeon Ha1, Hana Jang1, Namjeong Choi1
1School of life Sciences, Gwangju Institute of Science and Technology, Gwangju 500-712, Korea.
Abstract:
Alternative splicing (AS) is an important posttranscriptional regulatory process. Damaged or unnecessary cells need to be removed though apoptosis to maintain physiological processes. Caspase-2 pre-mRNA produces pro-apoptotic long mRNA and anti-apoptotic short mRNA isoforms through AS. How AS of Caspase-2 is regulated remains unclear. In the present study, we identified a novel regulatory protein SRSF9 for AS of Caspase-2 cassette exon 9. Knock-down (KD) of SRSF9 increased inclusion of cassette exon and on the other hand, overexpression of SRSF9 decreased inclusion of this exon. Deletion mutagenesis demonstrated that exon 9, parts of intron 9, exon 8 and exon 10 were not required for the role of SRSF9 in Caspase-2 AS. However, deletion and substitution mutation analysis revealed that AGGAG sequence located at exon 10 provided functional target for SRSF9. In addition, RNA-pulldown mediated immunoblotting analysis showed that SRSF9 interacted with this sequence. Gene ontology analysis of RNA-seq from SRSF9 KD cells demonstrates that SRSF9 could regulate AS of a subset of apoptosis related genes. Collectively, our results reveal a basis for regulation of Caspase-2 AS.
Insights
Researchers identified SRS Family Member 9 (SRSF9) as a novel regulator of Caspase-2 alternative splicing (AS). SRSF9 controls the balance between pro-apoptotic and anti-apoptotic Caspase-2 mRNA isoforms by targeting a specific sequence in exon 10.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- Alternative splicing (AS) is a crucial posttranscriptional regulatory mechanism.
- Apoptosis, the process of programmed cell death, is vital for maintaining physiological homeostasis.
- Caspase-2 pre-mRNA undergoes AS to produce both pro-apoptotic and anti-apoptotic mRNA isoforms, but its regulation is not fully understood.
Purpose of the Study:
- To identify novel regulatory proteins involved in the alternative splicing of Caspase-2.
- To elucidate the mechanism by which Caspase-2 alternative splicing is regulated.
Main Methods:
- Knock-down (KD) and overexpression of SRS Family Member 9 (SRSF9).
- Deletion and substitution mutagenesis of Caspase-2 pre-mRNA.
- RNA-pulldown assays.
- RNA sequencing (RNA-seq) and Gene Ontology (GO) analysis.
Main Results:
- SRSF9 was identified as a novel regulator of Caspase-2 alternative splicing (AS).
- SRSF9 KD increased cassette exon inclusion, while SRSF9 overexpression decreased it.
- A specific AGGAG sequence in exon 10 was identified as the functional target for SRSF9 binding.
- SRSF9 was shown to interact with this AGGAG sequence.
- RNA-seq analysis revealed that SRSF9 regulates AS of other apoptosis-related genes.
Conclusions:
- SRSF9 plays a critical role in regulating Caspase-2 alternative splicing.
- The AGGAG sequence in exon 10 is essential for SRSF9-mediated regulation of Caspase-2 AS.
- SRSF9 influences the balance of apoptosis-related gene splicing, impacting cellular processes.
Related Concept Videos
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
Caspases
CRISPR
CRISPR/Cas9 Genome Editing

